title: Targeting angiogenesis in chronic liver diseases with portal hypertension: anti-placenta growth factor inhibitor or multikinase inhibitor sorafenib?
authors.forename: Romain
authors.initials: R
authors.lastname: Coriat
authors.forename: Olivier
authors.initials: O
authors.lastname: Mir
authors.forename: François
authors.initials: F
authors.lastname: Goldwasser
authors.forename: Stanislas
authors.initials: S
authors.lastname: Pol
authors.forename: Stanislas
authors.initials: S
authors.lastname: Chaussade
mesh_terms: D000818:Animals; D006505:Hepatitis / Q000188:drug therapy*; D006801:Humans; D006975:Hypertension, Portal / Q000188:drug therapy*; D008103:Liver Cirrhosis / Q000188:drug therapy*; D008297:Male; D011257:Pregnancy Proteins / Q000037:antagonists & inhibitors*
chemical_list: D011257:Pregnancy Proteins